These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 6379717)

  • 1. Towards a rational drug usage in a state institution for retarded individuals.
    Huessy HR; Ruoff PA
    Psychiatr J Univ Ott; 1984 Jun; 9(2):56-8. PubMed ID: 6379717
    [No Abstract]   [Full Text] [Related]  

  • 2. [How should mentally handicapped adults with depressive disorders be treated psychopharmacologically?].
    Meins W
    Nervenarzt; 1996 Mar; 67(3):216-8. PubMed ID: 8901279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in psychotropic drug use in long-term residents of an ICF/MR facility.
    Hancock RD; Weber SL; Kaza R; Her KS
    Am J Ment Retard; 1991 Sep; 96(2):137-41. PubMed ID: 1681829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacologic management of psychiatric and behavioral symptoms in mental retardation.
    Madrid AL; State MW; King BH
    Child Adolesc Psychiatr Clin N Am; 2000 Jan; 9(1):225-43, x-xi. PubMed ID: 10674198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changing patterns of psychoactive drug use with the mentally retarded.
    White AJ
    N Z Med J; 1983 Sep; 96(739):686-8. PubMed ID: 6577342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Therapy with psychotropic agents of mentally retarded children].
    Kinze W
    Z Arztl Fortbild (Jena); 1983; 77(9):402-4. PubMed ID: 6880286
    [No Abstract]   [Full Text] [Related]  

  • 7. Empirical approach to psychopharmacology for institutionalized individuals with severe or profound mental retardation.
    Bishop AC
    Ment Retard; 1992 Oct; 30(5):283-8. PubMed ID: 1435282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychotropic medication efficacy graphs: an application of applied behavior analysis.
    Spirrison CL; Grosskopf LG
    Ment Retard; 1991 Jun; 29(3):139-47. PubMed ID: 1881344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Use of psychotropic medication among individuals with mental retardation].
    Baasland G; Engedal K
    Tidsskr Nor Laegeforen; 2009 Sep; 129(17):1751-3. PubMed ID: 19756056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment with psychotropic drugs in various facilities for mentally handicapped patients].
    Meins W; Auwetter J; Krausz M; Turnier Y
    Nervenarzt; 1993 Jul; 64(7):451-5. PubMed ID: 8103571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Psychotropic medicines to patients with mental retardation].
    Bygdnes AM; Kristiansen A
    Tidsskr Nor Laegeforen; 2007 Apr; 127(8):1028-30. PubMed ID: 17457386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A clinical pharmacy service to reduce psychotropic medication use in an institution for mentally handicapped persons.
    Inoue F
    Ment Retard; 1982 Apr; 20(2):70-4. PubMed ID: 7078402
    [No Abstract]   [Full Text] [Related]  

  • 13. Psychopharmacology of the retarded: present and future.
    Sprague RL
    Psychopharmacol Bull; 1978 Oct; 14(4):63-5. PubMed ID: 704765
    [No Abstract]   [Full Text] [Related]  

  • 14. Toward a functional analysis of drug treatment for behavior problems of people with developmental disabilities.
    Schaal DW; Hackenberg T
    Am J Ment Retard; 1994 Sep; 99(2):123-40. PubMed ID: 7803030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mental retardation. Behavior problems and psychotropic drugs.
    Rothman CB; Chusid E; Giannini MJ
    N Y State J Med; 1979 Apr; 79(5):709-15. PubMed ID: 286168
    [No Abstract]   [Full Text] [Related]  

  • 16. Implementation of an interdisciplinary psychotropic drug review process for community-based facilities.
    Lepler S; Hodas A; Cotter-Mack A
    Ment Retard; 1993 Oct; 31(5):307-15. PubMed ID: 8271941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of medication in a residential institution for mentally retarded persons.
    Silva DA
    Ment Retard; 1979 Dec; 17(6):285-8. PubMed ID: 534034
    [No Abstract]   [Full Text] [Related]  

  • 18. [Particular aspects of psychiatric management of mentally retarded patients with psychiatric disorders].
    Hennicke K; Meins W
    Psychiatr Prax; 1995 Nov; 22(6):240-3. PubMed ID: 8570755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interdisciplinary team review of psychotropic drug use in community settings.
    Kastner TA; Walsh K
    Ment Retard; 1994 Jun; 32(3):243-5; discussion 245-7. PubMed ID: 8084278
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of interdisciplinary team review on the use of antipsychotic agents with severely and profoundly mentally retarded persons.
    Glaser BA; Morreau LE
    Am J Ment Defic; 1986 Jan; 90(4):371-9. PubMed ID: 3946474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.